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Abstract
Objectives—To measure the processes of
care, health benefits and costs of outreach
clinics held by hospital specialists in
primary care settings.
Design—The study was designed as a
case-referent (comparative) study in
which the features of 19 outreach clinics
(cases) were compared with matched out-
patient clinics (controls). The measuring
instruments were self administered ques-
tionnaires. Patients were followed up at six
months to reassess health status. The spe-
cialties included in the study were cardiol-
ogy, ENT, general medicine, general
surgery, gynaecology and rheumatology.
Setting—Specialist outreach clinics in
general practice in England,withmatched
outpatient clinic controls.
Subjects—Consecutive patient attenders
in the outreach and outpatient clinics,
their specialists, the outreach patients’
general practitioners, practice managers
and trust accountants. Patients’ response
rate at baseline: 78% (1420).
Main outcome measures—Patient satis-
faction, doctors’ attitudes, processes and
health outcomes, costs.
Results—Outreach patients were more
satisfied with the processes of their care
than outpatients, their access to specialist
care was better than that for outpatients
and they were more likely to be dis-
charged. Doctors reported that the main
advantages of the outreach clinic were
improved patient access to specialists and
convenience for patients, in comparison
with outpatients, and most GPs and
specialists felt the outreach clinic was
“worthwhile”. At six month follow up, the
health status of the outreach sample had
significantly improved more than that of
the outpatients on all eight sub-scales of
the HSQ-12, but this was probably be-
cause of their better starting point at
baseline. The impact of outreach on
health outcomes was small. The NHS
costs of outreach were significantly higher
than outpatients. An increase in outreach
clinic size would reduce cost per patient,
but would lead to the loss of most of the
clinics’ benefits.
Conclusions—While the process of care
was of higher quality in outreach than in
outpatients, and the eYciency of care was
also greater in the latter, the eVect on
patients’ health outcomes was small. Re-
sponsiveness to patients’ views and pref-
erences is an essential component of good
quality service provision. However, the
greater cost of outreach raises the issue of
whether improvements in the quality and
eYciency of health care, without a sub-
stantial impact on health outcomes, is
money well spent in a publicly funded
health service. On the other hand, the real
costs of outreach in comparison with out-
patients clinics can probably only be truly
estimated in a longitudinal study with a
resource based costing model derived
from documented patient attendances and
treatment costs over time in relation to
longer term outcome (for example, at a
two year end point).
(J Epidemiol Community Health 2000;54:149–156)
The need to balance the supply of limited
resources and increasing demands for spending
on health care has led to international debates
on health care provision and priorities.1 2 In
some countries, such as the United Kingdom,
with well developed primary care systems, it
has also led to increasing attempts to shift the
balance of care increasingly from the secondary
to the primary care sector. The publicly funded
NHS, with its foundations laid on the principle
of equity, is popular among the British public
and reflects an ethos of community responsibil-
ity, in contrast with the prevailing individual-
ism that characterises private health care
systems.3 The well developed primary care sys-
tem, involving the general practitioner (GP) as
gatekeeper to further services, has helped to
keep health care costs down.4 Ninety per cent
of health care contact takes place in primary
care. Despite this, the unexplained variation in
GPs’ hospital referral rates, and increasing
healthcare costs, has led to the search for
methods of improving eYciency and
eVectiveness.4 5 Although strong primary care
based health care systems may have lower
costs,6 the advantages of promoting this shift
are not purely financial, and include the
benefits of providing greater coordinated and
continuous care. A later addition to the NHS
reforms, which drew largely on the US
literature on managed competition7 8 was GP
fundholding (which gave GPs control of their
own budgets for patient care).9–12 Policy makers
initially envisaged that fundholding would
enable GPs to counterbalance the entrenched
power of hospitals and achieve higher quality
and more accessible care for their patients,
albeit at risk of creating inequities between
practices.13 There is no good evidence that
fundholding increased the shift of care from
specialist to primary care services, or that
referral behaviour and quality of care
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improved.4 14 In the drive for greater eYciency,
policy makers have now turned their attention
to replacing GP fundholding schemes with new
local commissioning schemes within Primary
Care Goups, with GPs and other purchasing
bodies acting in partnership.15
The boundaries between health care systems
is becoming blurred with the widespread health
care reforms across Europe,16 the introduction
of market principles and managerialism,17 and
the direction of change in Eastern Europe
towards insurance based systems.18 However,
international diVerences also exist in the extent
of the coverage of populations with strong pri-
mary health care systems.19 Despite this, much
can be learned from diVerent systems about
cost eVective methods of organising health
care, and much of Europe is observing
developments in the NHS with interest.
Within the framework of the widespread
development of GP fundholding schemes dur-
ing the 1990s, specialist run clinics held in
general practice and community health care
settings (known as specialist outreach clinics)
have increased rapidly across England, and
numbers are reported to be large.20 The new
local commissioning schemes within PCGs,15
may give further impetus for the local purchas-
ing of specialist care in primary and commu-
nity settings, given their popularity among
GPs. Surveys of GPs and trusts20 have reported
that the most popular outreach specialties are
those with high patient volume and, in many
cases, long waiting lists—for example, in rheu-
matology, ENT, gynaecology, general surgery,
orthopaedics and dermatology.
While some specialists and trust executives
have mixed feelings about the cost-
eVectiveness of outreach services (in relation to
the best use of the specialists’ time), others
have been keen to establish the clinics as a
means of income generation, particularly in
surgical specialties where patients are referred
on to the trust for intervention, and in areas
where there is strong competition from neigh-
bouring trusts.20 While reviews have summa-
rised the advantages and disadvantages of out-
reach from the small amount of published
research,21–27 previous investigators have not
reached uniform conclusions about the costs
and benefits of outreach clinics in comparison
with outpatients. Part of the problem has been
the failure to control for the case mix eVects of
severity of condition and patient status (new/
follow up patient) because of relatively small
sample sizes.
Methods
STUDY DESIGN
The study reported here aimed to evaluate
outreach clinics held by hospital specialists
(consultants) in primary care settings (GPs’
surgeries), in comparison with hospital outpa-
tients as controls. The specialties included in
the study were cardiology, ENT, general medi-
cine, general surgery, gynaecology and paediat-
rics, rheumatology. The study was designed as
a case-referent study in which the features of
the specialists’ outreach clinics (cases) were
compared with the same specialists (consult-
ants) outpatient clinics (controls). This mini-
mised variation between the two types of clin-
ics that might have been attributable to the
eVects of diVerent specialists conducting them.
Self administered questionnaires were given
to patients in both clinic settings (health status,
satisfaction, processes, costs), specialists in
both clinics (individual patient clinical sheets
and a questionnaire about the processes of the
clinic and attitudes), GPs housing the outreach
clinics (individual patient clinical sheets and a
questionnaire about the processes of the clinic
and attitudes), their managers, and to the
accountants in the trusts holding the study
outpatient clinics (on costs). Patients were fol-
lowed up by mail to assess their health
outcomes six months later.
Outreach clinics were sampled from a
national screen of specialists, trusts and health
authorities that aimed to identify them. Nine-
teen outreach clinics were included in the
study, each with same specialist outpatient
clinic controls (one of these was a duplicate
covering two outreach clinics) from 14 hospital
trusts. The areas included were Yorkshire,
Greater Manchester, Merseyside and Lanca-
shire, Cheshire, Nottinghamshire, Leicester-
shire, SuVolk, Buckinghamshire, Warwick-
shire, Kent, Sussex, Devon, outer London and
Essex. The sample size of clinics and patients
was based on the number of clinics that could
be managed on a national basis, and that could
satisfy calculations for statistical power with the
patient and the clinic as the unit of analysis
(this was based on the detection of diVerences
of 15–20% between patient groups in the main
variables of interest, at a power of 80% and sig-
nificance at 5%).
MEASURES
Costs included patients’ personal costs (for
example, costs of travel, carers, child minders,
time); specialists’ travel costs and the oppor-
tunity cost of travel time (only applicable to the
outreach clinics); NHS staYng costs per clinic;
patients’ treatment costs (prescribed medi-
cation for the study condition, investigations
and interventions, including tests procedures,
treatment, surgery); NHS fixed overhead costs
(building, running and maintenance costs).
The measures used were those developed by
Gosden et al25 26 for their evaluation of outreach
clinics in dermatology and orthopaedics. As
with their study, the overhead cost information
was collected from managers and accountants
of general practices and hospital trusts, but was
excluded from the marginal costs (the addi-
tional cost to treat an extra patient) because of
the wide variation in the content and quality of
the data provided (despite many follow ups by
the researchers, the managers insisted that they
had provided us with all that was available, and
that further break downs and clarifications of
the cost data were not possible). This common
experience (that is, the collection of incompa-
rable data on overhead costs) questions the
feasibility and realism of the economic method
in relation to costing health services.
Process measures included waiting list times,
waiting times in clinics, number of follow up
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attendances, process outcome of consultation,
investigations and procedures performed, pa-
tient satisfaction with the clinics (using Davies
and Ware’s Visit Specific Patient Satisfaction
Survey questionnaire28), and staV attitudes
towards the clinics. Health status and outcome
at six months was measured using the Health
Status Questionnaire-12, version 1 (HSQ-
12.1), a short version of the Short-Form-36,29
and other health items; clinical case mix was
measured by a specialist’s rating of severity,
based on the Duke Severity of Illness Scale.30
Significant diVerences are presented by site
(outreach/outpatients). All analyses controlled
for patient case mix (measured by specialists’
ratings of severity of condition; patient re-
ported health status; patient status of new or
follow up patient). These analyses are reported
where diVerences between outreach and outpa-
tient clinic attenders were because of diVer-
ences in case mix. Reference is made to any
diVerences by specialty by site where apparent,
although most specialty diVerences were re-
duced to non-significance once case mix was
controlled for.
Univariate, bivariate, and multivariate analy-
ses were carried out, using frequency distribu-
tions, ÷2 tests, t tests, Wilcoxon’s test, Mann-
Whitney U test, analysis of variance, and
logistic regression. Attention has been drawn to
statistically significant diVerences that were
achieved at least at the p<0.05 level. Base
numbers vary because of some item non-
response.
RESPONSE RATES
All patients were approached consecutively as
they attended the clinics during the study
period and invited to participate. The ques-
tionnaires were prepared before the clinic start
time, and serial numbers were allocated to
patient names in the clinic appointments lists
and matched to patient hospital numbers.
These were checked after the clinic ended to
ensure no one had been missed, and the
non-attenders were noted. A total of 1747 out-
reach and outpatients consented to participate
in the study as they attended the clinics, and
109 refused. Their final response rate to the
baseline questionnaire was 78%
(1420):OR:82% (732); OP:74% (688). The
109 patients who refused to consent to the
study when approached in the clinics are
included in the non-response figures. Up to
four postal reminders were sent. Patients who
returned a questionnaire at baseline were sent a
six month follow up questionnaire; the re-
sponse rate was 75% (1060):OR:75% (546);
OP 75% (514). Up to four postal reminders
were sent at baseline and follow up.
All participating specialists were consultants.
All the general practices in the study were
fundholding, and two were multi-fundholders.
All specialists, GPs and their managers had
agreed in principle to complete the study ques-
tionnaires before the outreach clinic was
included in the study. All but one of the
specialists returned their outreach question-
naires (representing 18 outreach clinics—one
specialist was a duplicate as he held two of the
19 study outreach clinics); clinical sheets for
individual patients were returned by specialists
for 672 of the 732 responding outreach
patients (91%) and for 549 of their 688
responding outpatients (80%); 16 of 19
practice managers responded; 60 of 106 (57%)
GPs with the outreach clinics (representing 17
of 19 practices) returned their outreach
questionnaires (four of these claimed that the
questionnaire should be accepted as represen-
tative of all the views of all the doctors in the
practice (number of partners = six in each
case)); clinical sheets for individual patients
were returned by GPs for 434 of their 732
responding outreach patients (59%) (GPs of
outpatients were not included in the study); all
14 trust accountants responded.
Results
THE CLINICS
The main reason reported by each GP practice
(one GP representing each practice provided
this information) for establishing the clinic was
improvement of accessibility convenience to
patients (GP practices: 94%, 15; specialists:
44%, 8), followed by reduction of waiting times
for a specialist opinion (81%, 13); this was also
the most commonly cited reason by specialists
(44%, 8). The hospital trusts’ motivation was
financial (to gain income from referrals from
outlying practices who did not previously refer
patients to that hospital).
The outreach clinics were held, on average,
every four weeks, in comparison with weekly
outpatient clinics. The specialists reported that
the outreach clinics lasted on average 3.03
hours—similar to the 3.50 hours for outpa-
tients. The outreach clinics had between 6 and
28 slots (mean:15.8) and outpatients had
between 8 and 43 appointment slots (mean:26)
(t test:4.4; df:16; p<0.0001). Non-attendance
figures were collected from records on each site
by the researchers. The outreach clinics had
lower non-attendance rates than outpatient
clinics: 10% (98):16% (117) (÷2:17.25; 1 df;
p<0.0001). Outreach patients waited, on aver-
age, 5.4 weeks (95%CI 5.0, 5.7) to see the spe-
cialist for their first appointment, which was
2.4 weeks less than outpatients who waited, on
average, 7.8 weeks (t test:−6.31; df: 758.91;
p<0.001). The outreach group also waited for
less time, on average, at the clinic to see the
specialist:14.4 minutes, in comparison with
29.9 minutes for outpatients (on average, 15.5
minutes less) (t test:−11.18; 1023.08 df;
p<0.001).
Forty four per cent (8) of the specialists
reported that they conducted the outreach
clinic during their NHS time, 28% (5)
conducted the clinic as an extra NHS session
22% (4) conducted it during private time, and
6% (1) reported it was conducted during other
times. Fifty six per cent (10) of the specialists
reported that they took the patient hospital
notes to the outreach clinic and 41% (7) took
equipment. Fifty six per cent said that when
they referred outreach patients on to the hospi-
tal for tests, investigations, procedures or
surgery, they were placed on the normal NHS
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waiting list, and 44% (8) said they gave them
the next available appointment, independently
of the NHS waiting list.
PATIENT CHARACTERISTICS, HEALTH STATUS AND
HEALTH OUTCOME
There were no diVerences with patient age, sex
or severity of condition (specialist ratings) by
site of clinic. Thirty two per cent (414) of all
patients were male and 68% (902) were female.
Seven per cent (103) were aged <16, 4% (60)
were 16<25; 31% (425) 25<45; 35% (493)
45<65; 23% (314) were aged < 65. Fifty two
per cent (581) of all patients were rated as low
severity, 31% (354) were medium severity, and
17% (192) were high severity. Outreach
patients were more likely than outpatients to be
new rather than follow up attenders:60%
(390), in comparison with 26% (136) in
outpatients (÷2:134.5, 1 df, p<0.00001). Thirty
four per cent (206) of the outreach patients,
compared with 26% (150) of outpatients, had
experienced their condition for less than a year
(÷2:30.4; 6 df; p<0.0001), which is consistent
with their greater likelihood of being new
rather than follow up patients.
Table 1 shows that, at both baseline and fol-
low up, outreach patients had slightly higher
HSQ-12 scores than outpatients, indicating
better health status (six of the eight sub-scales
are shown in table 1, the remaining two were
dichotomously scored and showed similar
trends). Outreach patients were also more
likely to have significantly improved health sta-
tus change scores for health perceptions (their
improved follow up scores being a likely eVect
of their better starting point), although actual
point changes were in fact relatively small
(table 1).
In relation to the 20 items on other and
important areas of life aVected, both outreach
and outpatients reported significantly fewer
limitations by follow up. (1) baseline: outreach
mean 5.4; outpatients mean 7.0; (2) follow
up; outreach mean 4.4, outpatients 5.16 (t val-
ues:outreach:4.86, p<0.001, eVect size:0.17;
outpatients:2.57, p<0.01, eVect size:0.08),
although the mean changes were not signifi-
cantly greater between sites (mean change:out-
reach −0.91, outpatients −0.54). The trends
were similar for the Rand and the other disease
impact items (tables available from author).
At follow up, more of the outreach (22%,
111) than the outpatients (13%, 66) rated the
change in their health status as “cleared up
altogether”, although similar proportions of
outreach (35%, 178) and outpatients (37%,
182) said it had “improved” (compared with
“not changed”, “got worse” or “other” —that
is, “too early to say”) (÷2:23.6; 4 df; p<0.0001).
PATIENT REPORTS OF PROCESS OUTCOMES
Significantly more outreach patients than out-
patients were completely discharged (com-
pared with being referred to other services,
treatment, surgery or given a follow up
appointment) after the sampled clinic attend-
ance:36% (246):27% (172) (÷2:12.8; 1 df;
p<0.001). Similarly, fewer outreach than
outpatients reported being given follow upTa
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appointments after the sampled (baseline)
consultation:37% (254), in comparison with
55% (346) outpatients (÷2:41.6; 1 df;
p<0.00001). Logistic regression analysis con-
firmed the independent eVect of site over new/
follow up patient status and severity of
condition (tables available from the authors).
Taking just the patients who reported that
they did not expect to see the specialist in the
clinic again (n=418), their use of specialist
facilities was not necessarily discontinued: 32%
(78) of these outreach patients and, a similar
proportion, 29% (50) of these outpatients said
that, while they had not been given another
clinic appointment, they had been referred on
by the specialist for surgery or investigations at
the hospital. There were no diVerences be-
tween new and follow up attenders. This
implies that the true costs of outreach in com-
parison with outpatient clinics can probably
only be truly estimated in a longitudinal study
with a resource based costing derived from
documented attendances, tests, procedures,
surgery, prescriptions and so on, in relation to
final outcome (for example, at a two year end
point).
PATIENT SATISFACTION
Outreach patients were more satisfied than
outpatients with all but one of the the process
and quality issues asked about in the Site Spe-
cific Satisfaction battery. In particular, out-
reach patients were much more likely to be
more satisfied than outpatients in relation to
the convenience of the location of the clinic.
Most of the least diVerences (although still sig-
nificant) occurred in relation to the character-
istics of the specialist, which would be expected
given that it was the same specialist in each
paired setting, perhaps only influenced by the
very diVerent pressures in each setting (for
example, diVerent size clinic lists): explanation
of treatment; thoroughness, carefulness and
competence of specialist; and the personal
manner of the specialist. There was no
diVerence by site and satisfaction with
advocacy/interpretation facilities (because of
the small numbers the question did not apply
to most respondents) (see table 2).
Outreach patients were slightly less likely than
outpatients to report at baseline that their treat-
ment could have been improved, although the
diVerence was significant: 15% (96), 22% (125)
(÷2:10.4; 2 df; p<0.01), although by follow up
this diVerence no longer retained significance
(22% (107), 27% (118) respectively).
Patients’ open responses suggesting areas of
improvement to the clinic service were coded.
The most commonly mentioned area was the
need for more information on their condition
and the treatment/procedures undertaken:17%
(14) of outreach and 23% (23) of outpatients
said this (not significantly diVerent). Seventy
five per cent (538) of the outreach patients
reported that they preferred to see the special-
ist in their GP’s surgery, than in outpatients,
compared with 36% (243) of outpatients (who
were asked this hypothetically) (÷2:262.9; 3 df;
p<0.001). Modelling indicated that, although
site remained independently significant, a large
proportion of these site diVerences were also
explained by the smaller clinic sizes in
outreach, in comparison with outpatients
(tables available from authors).
DOCTORS’ VIEWS ON THE OUTREACH CLINICS
Doctors were asked about the advantages and
disadvantages of the outreach clinic. Their atti-
tudes (shown in table 3) coincided with their
main reasons for setting up the clinic, which
suggests that they felt that their expectations
had been met.
The most commonly cited advantage of the
outreach clinics by both the GPs and specialists
Table 2 Patient satisfaction : clinic location and facilities
Outreach % (n) Outpatient % (n)
Advocacy interpretation facilities†
Excellent/very good 86 (19) 75 (21)
Good/fair 9 (2) 18 (5)
Poor 5 (1) 7 (2)
Convenience of location
Excellent/very good 81 (568) 36 (229)*****
Good/fair 18 (125) 56 (354)
Poor 1 (6) 8 (52)
Ease of making/changing appointment
Excellent/very good 72 (143) 58 (147)**
Good/fair 26 (52) 37 (94)
Poor 2 (5) 5 (14)
Phoning clinic
Excellent/very good 69 (197) 49 (137)****
Good/fair 28 (82) 46 (130)
Poor 3 (8) 5 (13)
Convenience of appointment day/time
Excellent/very good 67 (466) 48 (300)*****
Good/fair 31 (213) 49 (310)
Poor 2 (11) 3 (18)
Waiting area
Excellent/very good 64 (443) 40 (255)*****
Good/fair 34 (236) 53 (339)
Poor 2 (16) 7 (45)
Patient satisfaction : staV attitudes and waiting times
Personal manner of specialist
Excellent/very good 75 (517) 67 (425)**
Good/fair 21 (145) 29 (186)
Poor 4 (30) 4 (25)
Personal manner of reception staV
Excellent/very good 73 (506) 63 (405)****
Good/fair 26 (184) 36 (228)
Poor 1 (7) 1 (6)
The clinic visit overall
Excellent/very good 73 (501) 55 (342)*****
Good/fair 26 (177) 42 (258)
Poor 1 (6) 3 (18)
Thoroughness, carefulness and competence of specialist
Excellent/very good 71 (496) 62 (393)***
Good/fair 27 (184) 34 (215)
Poor 2 (14) 4 (26)
Attention of specialist to what patient said
Excellent/very good 67 (464) 56 (354)****
Good/fair 30 (204) 40 (253)
Poor 3 (24) 4 (30)
Length of wait at clinic
Excellent/very good 66 (452) 40 (256)*****
Good/fair 29 (199) 48 (303)
Poor 5 (38) 12 (75)
Explanation of treatment
Excellent/very good 63 (430) 52 (327)*****
Good/fair 33 (225) 41 (259)
Poor 4 (27) 6 (42)
Wait for appointment
Excellent/very good 60 (416) 47 (295)****
Good/fair 34 (237) 43 (278)
Poor 6 (39) 10 (61)
Time spent with specialist
Excellent/very good 60 (412) 41 (263)*****
Good/fair 37 (258) 53 (335)
Poor 34 (21) 6 (39)
Number of respondents‡ 200–699 255–639
**p<0.01, ***p<0.001, ****p<0.0001, *****p<0.00001.
†Advocacy base number: 22 outreach and 28 outpatients (as not all patients needed access to these
and they were not required).
‡Base numbers drop to 200–255 just for all other items that did not apply to all respondents (this
was for phoning the clinic and changing appointment, did not apply to respondents who had not
attempted to do this).
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was the improvement of patient access to the
specialist and convenience to the patient,
followed by reduced waiting time for appoint-
ments. Other commonly cited advantages were
improved goodwill, and also communication
between GPs and specialists.
The most commonly cited disadvantage of
the outreach clinic was said by GPs to be the
inflexible or infrequent follow up intervals (that
is, if the specialist attends just once a month or
every six weeks then follow up consultations
are delayed until then). The next most
common disadvantage they mentioned was the
increase in the GP administrative time and
costs. The most common disadvantage cited by
specialists was the reduction in the specialist
time in hospital (NHS), followed by their trav-
elling time.
Ninety six per cent (53) of the GPs and 88%
(15) of the specialists reported that they felt
that the outreach clinic was “worthwhile”;
there were no diVerences by specialty of the
clinic. Thirty nine per cent (7) of the specialists
were planning other outreach clinics.
Fifty eight per cent (11) of the 19 specialists
held education/training sessions (called “teach
and treat”) with the GPs, although just 26% (5)
reported having regular contact with the GPs at
the outreach clinics. Both GPs and specialists
reported a change in referral patterns to the spe-
cialist since the establishment of the outreach
clinic: 46% (26) of the GPs and 33% (6) of the
specialists reported a decline in numbers of
referrals, although 13% (7) of GPs and 6% (1)
of specialists reported an increase; 5% (3) of
GPs and 17% (3) of specialists reported a diVer-
ent type of referral and the remainder said there
had been no change (32%, 18; 33% (6) respec-
tively) or they did not know (4% (2), 11% (2)
respectively). Data from the practice managers
(controlling for list size over time) confirmed a
reduction in referrals by a third. Twenty two per
cent (4) of the specialists reported that the
appropriateness of the GP referrals had changed
(that is, more appropriate) as a result of the out-
reach clinic, 61% (11) said they had not and the
remainder said it was too early to tell or they
were uncertain.
COSTS
The mean total cost to the patient (travel, cost of
care for dependents and opportunity costs) was
£9.97 in outpatients and £4.55 in outreach, a
diVerence of −£5.42 (t value:12.70. p<0.001).
This was attributable largely to diVerences in the
distance travelled, and associated costs. Out-
reach patients travelled shorter distances to and
from the clinics than outpatients at 7.0 (95%CI
6.4, 7.7) miles in comparison with 19.0 (95%CI
16.3, 21.7) miles for outpatients (on average 12
miles less (95%CI −14.8, −9.3) (t test −8.40;
p<0.001).
The mean total NHS treatment costs
(prescribed medication for the study condition,
investigations and interventions (treatment,
surgery) per patient were significantly higher in
outreach than outpatients:£163.73: £109.20
(95%CI 127.69, 199.77; 79.86, 138.54), t
value 2.30, p<0.05.
The mean diVerence was £54.53 (95%CI
8.09, 100.97). The higher overall treatment
costs in outreach only partly reflected the
greater number of new attenders in the
outreach clinics. The mean total treatment
costs for new attenders were still higher in
outreach—at over £50 per patient greater in
outreach than in outpatients. In all specialties,
the mean medical and nursing staYng costs in
outreach were significantly higher at £2.73
(95%CI 2.17, 3.30) per patient more than
Table 3 Specialists’ and GPs’ views of the advantages and disadvantages of the outreach clinic
Specialists GPs
% (n) % (n)
Advantages
Improves accessibility/convenience for patients 100 (18) 95 (54)
Reduces waiting times for patients to get appointments 72 (13) 88 (50)
Promotes goodwill 67 (12) 54 (31)
Improves communication between GPs and specialists 61 (11) 74 (42)
Improves access to outpatient clinics for NHS patients 56 (10) 60 (34)
Fewer non-attenders at outreach in comparison with outpatient clinics 56 (10) 67 (38)
To secure fundholder contracts for hospital 56 (10) 7 (4)
Improves specialists’ job satisfaction 22 (4) — NA
Personal financial benefits for specialist 22 (4) 5 (3)
Broadening of GPs’ skills 11 (2) 44 (25)
Improves access to private referrals 6 (1) 2 (1)
Having hospital notes 6 (1) — NA
Improves GPs’ job satisfaction — NA 49 (28)
Cheaper service than outpatients — NA 44 (25)
Other advantages 11 (2) 4 (2)
No advantages — (0) 2 (1)
Disadvantages
Reduces specialist time in hospital (NHS) 72 (13) 22 (12)
Travelling time for specialist 67 (12) — NA
Reduces specialists’ time for other work 50 (9) — NA
Inflexible/infrequent follow up intervals 39 (7) 93 (51)
Specialist having to bring hospital notes 39 (7) — NA
Reduces training time for junior hospital doctors 39 (7) — NA
Fewer patients seen per clinic than in outpatients 28 (5) 11 (6)
Not having hospital notes 22 (4) 9 (5)
Inadequate administrative back up in GPs’ surgeries 11 (2) — NA
Increase in GPs’ administrative costs/time — NA 43 (25)
Less time for GPs’ other work — NA 6 (3)
Other disadvantages 11 (2) 4 (2)
No disadvantages — (0) 27 (15)
Number of respondents 18 55–57
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outpatients (£13.80 in outreach and £11.07 in
outpatients (t value 9.46, p<0.0001)).
The mean opportunity cost for outreach (the
opportunity cost of staV travel times and travel
costs applied only to the outreach clinics) was
£1.72 (95%CI 1.62, 1.82) per outreach
patient. Their time should not strictly be
included for the calculation of opportunity cost
as they were engaged in NHS work. However,
for information, the mean opportunity cost of
the specialist clinic time, including travelling
time (although excluding travel costs)
was:£137 (95%CI 128, 145). The mean of
each of these costs to outreach per patient was
£15.52 (£13.80+£1.72), in comparison with
£11.07 (95%CI 10.72, 11.42) in outpatients (a
mean diVerence of £4.45 per patient (t test
16.45, df 1297.18, p<0.001). The overhead
costs are not given here as the practice and
trust figures were not standardisable (tables
available from authors).
Further analyses, using analysis of variance,
of the outreach clinic costs showed that the
smallest outreach clinics (10 or fewer patients
booked) cost almost twice as much to staV as
the largest clinics (20 or more patients
booked). This was because of the fixed costs of
travelling to and from the clinic, and setting it
up, were distributed across a smaller number of
patients (tables available from the authors).
Discussion
In contrast with countries without a strong pri-
mary care infrastructure, people in the UK
have good access to primary care physicians
(GPs). However, apart from containing costs,
one of the main health care problems in the UK
is speeding up access to specialist services in
the secondary care sector. Policy makers in the
UK have driven organisational changes in the
primary care sector in the light of these issues.
This is the first large study of the costs and
benefits of one of the service developments to
arise largely from GP fundholding practices.
While specialist outreach clinics are not unique
to fundholding practices, they were relatively
rare before, and fundholding led to a large
increase in their numbers.
The study reported here showed that, while
patient satisfaction levels in outreach were
superior to outpatient clinics, their access to
specialist care was greater than that of
outpatients, and they were more likely to be
discharged, the health benefits were little
greater than in outpatients. Like the evaluation
of dermatology and orthopaedics outreach
clinics25 26 the study reported here found that
the NHS costs were significantly higher in out-
reach than outpatient clinics. Both studies also
found that communication between GPs and
specialists was limited. Unlike the former
evaluation, which reported that dermatology
outreach patients were less enthusiastic about
seeing the specialist in the GP surgery,
compared with in hospital, the majority of out-
reach patients, across all specialties, in the
study reported here were positive about the
outreach clinic. They were far more satisfied
than outpatients about the processes of the
clinic. Both studies, however, reached the same
conclusion overall—that if the increasing de-
mand for outreach clinics is met, the workload
of the specialist in hospital could be adversely
aVected. In conclusion, while the process of
care was of higher quality in outreach than in
outpatients, and eYciency was also greater in
the outreach setting, this was at a substantially
higher cost, and the eVect on patient health
outcomes was small. The policy implication,
which is also of international relevance, is that,
in the short-term, the costs of health care are
more likely to be contained by retaining the
current hospital outpatient system alone, rather
than supplementing this with specialist out-
reach services to individual practices where
fewer patients can be seen, investigative
technology is often unavailable, and with
consequences for costs. However, the real costs
of outreach in comparison with outpatients
clinics can probably only be truly estimated in
a longitudinal study with a resource based
costing model derived from documented pa-
tient attendances and treatment costs over time
in relation to longer term outcome (for
example, at a two year end point). In addition,
the greater eYciency of outreach in compari-
son with outpatient clinics also needs to be
measured over time. The question remains: Is
the one third reduction in direct referrals to
outpatient departments from outreach prac-
tices, the lower non-attendance rates in out-
reach, the increase in appropriate outpatient
referrals from outreach practices (reported by
over a fifth of the specialists), together with the
higher patient discharge rate in outreach,
maintained, or even accelerated, over time? If
outreach results in an increasing number of
more appropriate referrals to specialists over
time then their increased costs may be judged
to be worthwhile.
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KEY POINTS
x Outreach patients were more satisfied
than outpatients in relation to the proc-
esses of their care.
x Patient access to specialist care was better
in outreach than in outpatient clinics.
x EYciency of care was greater in outreach
than outpatient clinics, with outreach
patients being more likely than out-
patients to be discharged.
x The health status of the outreach sample
had improved slightly more than that of
the outpatients.
x While patients’ own costs were lower,
NHS staYng and treatment costs were
more expensive per patient in outreach
than outpatient clinics.
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